Non-adherence to prescribed therapy has long been a serious issue that may lead to detrimental consequences for patient outcomes. Indeed, an alarming number of patients with chronic conditions never even initiate their prescribed therapy. For instance, up to half of patients diagnosed with hyperlipidemia and nearly a third of those with HIV don’t fill their prescriptions,1那些这样做的人经常在治疗的第一年停止使用。
在启动治疗之前,需要评估患者的实验室价值观,或者在治疗过程中进行监测,这是加剧已经很棘手的问题的另一个障碍。前往诊所吸血的旅行会阻止许多患者在最好的时间开始并遵守他们的治疗,但是现在,由于COVID-19的大流行的影响,这尤其繁重,因为可能需要个人来庇护到位。。
在分散临床试验中经常使用的室内静脉切开术服务是使患者在大流行期间及以后更容易的一种解决方案。
With IQVIA’s latest in-home phlebotomy services, nurses or phlebotomists can easily be deployed to support patients who are prescribed drugs for which blood draws or laboratory workups are requisite clinical standards. Our in-home phlebotomy services are structured to connect the multiple parties involved in the blood collection and analysis process.
IQVIA计划旨在支持特定的处方,而不是医生可以在合同参数之外要求的一般静脉造口术服务;只有PI中的实验室才能订购。为了确保其服务符合所有法规和医疗标准,它是结构化的
通过利用IQVIA的远程放血服务,制药公司可以通过消除实验室障碍来确保患者接受并继续进行处方治疗,以更好地支持处方依从性。了解更多,contact us。
1Final % claims not paid (1H20), IQVIA LAAD Claims Data.